Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

André Rogatko

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Entropy (Basel, Switzerland)|August 29, 2024
Dose Finding in Oncology Trials Guided by Ordinal Toxicity Grades Using Continuous Dose LevelsMourad Tighiouart, André Rogatko
Plos One|March 26, 2014
Escalation with overdose control using time to toxicity for cancer phase I clinical trialsMourad Tighiouart, Yuan Liu, André Rogatko
Statistics in Medicine|April 11, 2016
A Bayesian adaptive design for estimating the maximum tolerated dose curve using drug combinations in cancer phase I clinical trialsMourad Tighiouart, Quanlin Li, André Rogatko
Statistics in Medicine|May 15, 2014
Dose finding with drug combinations in cancer phase I clinical trials using conditional escalation with overdose controlMourad Tighiouart, Steven Piantadosi, André Rogatko
Journal of Biopharmaceutical Statistics|September 1, 2017
A Bayesian adaptive design for cancer phase I trials using a flexible range of dosesMourad Tighiouart, Galen Cook-Wiens, André Rogatko
Plos One|January 10, 2019
Comparison between continuous and discrete doses for model based designs in cancer dose findingMárcio Augusto Diniz, Mourad Tighiouart, André Rogatko
Statistics in Medicine|May 24, 2005
Flexible Bayesian methods for cancer phase I clinical trials. Dose escalation with overdose controlMourad Tighiouart, André Rogatko, James S Babb
Theoretical Population Biology|November 1, 2002
Hardy-Weinberg equilibrium diagnosticsAndré Rogatko, Michael J Slifker, James S Babb
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2021
Evaluating the Association of Adverse Events and Patient-Reported Symptoms to Endocrine Therapy TolerabilityN Lynn Henry, André Rogatko, Patricia A Ganz
Entropy (Basel, Switzerland)|May 10, 2016
Escalation with Overdose Control is More Efficient and Safer than Accelerated Titration for Dose FindingAndré Rogatko, Galen Cook-Wiens, Mourad Tighiouart, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Entropy (Basel, Switzerland)|August 29, 2024
Dose Finding in Oncology Trials Guided by Ordinal Toxicity Grades Using Continuous Dose LevelsMourad Tighiouart, André Rogatko
Plos One|March 26, 2014
Escalation with overdose control using time to toxicity for cancer phase I clinical trialsMourad Tighiouart, Yuan Liu, André Rogatko
Statistics in Medicine|April 11, 2016
A Bayesian adaptive design for estimating the maximum tolerated dose curve using drug combinations in cancer phase I clinical trialsMourad Tighiouart, Quanlin Li, André Rogatko
Statistics in Medicine|May 15, 2014
Dose finding with drug combinations in cancer phase I clinical trials using conditional escalation with overdose controlMourad Tighiouart, Steven Piantadosi, André Rogatko
Journal of Biopharmaceutical Statistics|September 1, 2017
A Bayesian adaptive design for cancer phase I trials using a flexible range of dosesMourad Tighiouart, Galen Cook-Wiens, André Rogatko
Plos One|January 10, 2019
Comparison between continuous and discrete doses for model based designs in cancer dose findingMárcio Augusto Diniz, Mourad Tighiouart, André Rogatko
Statistics in Medicine|May 24, 2005
Flexible Bayesian methods for cancer phase I clinical trials. Dose escalation with overdose controlMourad Tighiouart, André Rogatko, James S Babb
Theoretical Population Biology|November 1, 2002
Hardy-Weinberg equilibrium diagnosticsAndré Rogatko, Michael J Slifker, James S Babb
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2021
Evaluating the Association of Adverse Events and Patient-Reported Symptoms to Endocrine Therapy TolerabilityN Lynn Henry, André Rogatko, Patricia A Ganz
Entropy (Basel, Switzerland)|May 10, 2016
Escalation with Overdose Control is More Efficient and Safer than Accelerated Titration for Dose FindingAndré Rogatko, Galen Cook-Wiens, Mourad Tighiouart, et al.
Pageof 5